Compare Novavax Inc (NVAX) vs Tripadvisor Inc Common Stock (TRIP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Tripadvisor Inc Common Stock — how do they compare? Novavax Inc trades at $8.08 (market cap $1.30B), while Tripadvisor Inc Common Stock trades at $13.82 (market cap $1.68B). The key difference: Tripadvisor Inc Common Stock is the larger of the two by market cap. Which is the better fit depends on your goals.
| NVAX | TRIP | |
|---|---|---|
Market Cap | $1.30B | $1.68B |
Sector | Health | Consumer Cyclical |
52-Week High | $11.19 | $19.14 |
52-Week Low | $6.22 | $9.24 |
Enterprise Value | $800.50M | $1.80B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Tripadvisor Inc Common Stock
TripAdvisor is the world's leading travel metasearch company. The website offers 1 billion reviews and information on about 8 million accommodations, restaurants, experiences, airlines, and cruises. In 2021, 74% of revenue came from the company's core segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 20% of sales in 2021, and TheFork, its dining brand, represented 9% of revenue (about 3% of sales were intersegment, which are eliminated from consolidated revenue).
Read more on TRIP →
